Skip to main content
. 2021 Jan 18;26(2):484. doi: 10.3390/molecules26020484

Table 4.

The relative AUC(0–t) in rats after oral administration of CAT3 or SMEDDS.

Group CAT3 in Plasma Metabolite PF403 in Plasma
AUC(0–t) ng/L·h Relative AUC(0–t)(%) AUC(0-t) ng/L·h Relative AUC(0–t)(%)
CAT3 5.911 ± 0.396 100.00 20.537 ± 0.256 100.00
SMEDDS 10.564 ± 0.154 ** 178.72 10.008 ± 0.677 ** 48.73
CAT3 + Inhibition 1.862 ± 0.356 ** 31.50 5.747 ± 0.333 ** 29.98
SMEDDS + Inhibition 1.235 ± 0.166 ## 11.69 Note 1 5.542 ± 0.455 ## Note 1 55.38 Note 1

** p < 0.01 vs. CAT3-API, ## p < 0.01 vs. CAT3-SMEDDS. Note 1: AUC (0–t) ng/L·h vs. SMEDDS.

HHS Vulnerability Disclosure